Yesterday, February, 02, 2022, President Joe Biden announced a relaunch of the “cancer moonshot” project he oversaw during the Obama administration — and was introduced by Dr. Edjah Nduom, who was honoured and appointed by the U.S. President to lead the fight against cancer in the project.

Edjah Nduom is the son of Ghanaian business mogul and politician Dr. Papa Kwesi Nduom and was also appointed to chair the Young Neurosurgeons Committee of the American Association of Neurological Surgeons in April, 2021.

Edjah K. Nduom, MD, FAANS, is an Associate Professor in the Department of Neurosurgery at Emory University School of Medicine. A fellowship-trained and board certified neurosurgical oncologist, Dr. Nduom’s clinical specialty is the surgical management of brain and spinal cord tumors. He is particularly interested in the safe resection of malignant tumors located in eloquent areas of the brain, the brainstem and spinal cord.

Dr. Nduom is a member of the Cancer Immunology Research Program at Winship Cancer Institute of Emory University. He holds numerous positions in national and international medical societies. Notably, he is Co-Founder and Diasporan Representative of the Society for Neuro-Oncology Sub-Saharan Africa; International Outreach Committee Co-Chair of the Society for Neuro-Oncology; Membership Director of the Joint Tumor Section of the American Association of Neurological Surgeons and Congress of Neurological Surgeons; and Member of the Board of Directors of the National Brain Tumor Society.

Education

Dr. Nduom received his MD from University of Pennsylvania in Philadelphia, Pennsylvania. He completed a residency in Neurosurgery at Emory University in Atlanta, Georgia. He completed a Research Fellowship in Neurosurgical Oncology in the Surgical Neurology Branch of the National Institute of Neurological Disorders and Stroke in Bethesda, Maryland, and an additional Neurosurgical Oncology Fellowship at MD Anderson Cancer Center in Houston, Texas.

Research

Dr. Nduom’s research focuses on the modulation of the immune system for the treatment of malignant brain tumors. He has presented his translational and clinical work on immune therapy for brain tumors at numerous national and international meetings.

Awards

Dr. Nduom has received several awards over the course of his career. Recent awards include:

Academy Emerging Investigator by the American Academy of Neurological Surgery

National Institutes of Health Director’s Award

40 under 40 Leader in Minority Health by the National Minority Quality Forum